Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – When patients make sequential position changes during colonoscopy examinations, instead of remaining in the left lateral position, the improvement in luminal distension leads…
NEW YORK (Reuters Health) – Patients with severe aortic stenosis and reduced left ventricular systolic function may do better with transcatheter implantation of a prosthetic aortic valve than…
NEW YORK (Reuters Health) – Women with breast cancer treated with anthracycline-taxane based regimens are more likely to become amenorrheic than women treated with just anthracyclines or conventional…
NEW YORK (Reuters Health) – Very elderly patients, perhaps up to 100 years old, with acute ischemic stroke benefit from timely thrombolytic therapy to the same degree as…
NEW YORK (Reuters Health) – Results of in vitro testing indicate that silver impregnation of urinary catheters has little effect on bacterial adherence, reinforcing findings from clinical studies…
NEW YORK (Reuters Health) – Combined multichannel intraluminal impedance monitoring (MII) and pH monitoring in the esophagus detects gastroesophageal reflux (GER) in children more accurately than pH monitoring…
NEW YORK (Reuters Health) – Patients who develop acute renal failure (ARF) after undergoing coronary artery bypass grafting have a poorer prognosis if the condition doesn’t resolve within…
As a physician, has a frivolous lawsuit been brought against you?Have you been a victim of sham peer review?Have you been accused of disruptive physician behavior?We can help…
NEW YORK (Reuters Health) – Chronic Chagas disease in the elderly doubles their risk of dying from a stroke, and the risk is increased further in those with…
NEW YORK (Reuters Health) – After first-line treatment with bevacizumab plus interferon-alpha2a, subsequent therapy with tyrosine kinase inhibitors (TKIs) improves survival in patients with metastatic renal cell carcinoma,…
